Why Taking GLP-1s Before Surgery Could Be Fatal (Aspiration Risk Explained)

The Cutting Edge #26

Are you currently taking a GLP-1 medication (like Ozempic, Wegovy, Mounjaro, or Zepbound) and planning for plastic surgery or general anesthesia? In this critical episode of The Cutting Edge Podcast, host Mel sits down with bariatric therapist Ashlyn Douglass-Barnes and board-certified plastic surgeon Dr. Omar Beidas to unpack the medical, psychological, and surgical risks every patient must know.

If you are navigating weight loss surgery, post-bariatric skin removal, or GLP-1 therapy, this video explains why stopping your injection before surgery isn't optional—it could literally save your life.

👇 SUBSCRIBE for transparent, expert-backed insights on bariatric recovery and plastic surgery!

https://www.youtube.com/c/OurSleevedLifePodcast?sub_confirmation=1

🌟 IN THIS EPISODE:

While GLP-1 medications are revolutionary for weight loss and metabolic health, they carry a hidden risk under general anesthesia: delayed gastric emptying. Dr. Beidas breaks down the surgical science of aspiration risk (when undigested food enters the lungs during surgery) and explains why his practice strictly mandates stopping GLP-1s $2\text{ weeks}$ before surgery and holding them for at least $4\text{ weeks}$ post-op to ensure proper protein intake for wound healing.

We also tackle:

Debunking "Microdosing": Why surgeons hate this non-medical term and what smaller/frequent dosing actually means.

Gray Market Peptides & Retatrutide ("Reta"): The extreme dangers of buying unregulated peptides online vs. joining official clinical trials via clinicaltrials.gov.

Mental Health & Dopamine: How GLP-1s impact mood, anhedonia ("feeling meh"), food noise, and addiction pathways.

Visceral vs. Subcutaneous Fat: Why losing 20lbs--30lbs of internal organ fat with GLP-1s before a tummy tuck leads to vastly superior surgical results.